Bharat Biotech's Covaxin gets WHO approval for Emergency Use Listing (EUL). Covaxin vaccine was also reviewed by WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), and recommended use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above: WHO
No comments:
Post a Comment